相似文献
1
Corrigendum: Cross-reactive humoral and CD4 T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population.勘误：哥伦比亚人群中针对Mu和Gamma SARS-CoV-2变体的交叉反应性体液和CD4 T细胞反应。
Front Immunol. 2023 Aug 16;14:1274753. doi: 10.3389/fimmu.2023.1274753. eCollection 2023.
2
Longitudinal Follow-Up of the Immunity to SARS-CoV-2 in Health Care Workers in Argentina: Persistence of Humoral Response and Neutralizing Capacity after Sputnik V Vaccination.阿根廷卫生保健工作者对 SARS-CoV-2 免疫力的纵向随访：接种卫星 V 疫苗后体液反应和中和能力的持久性。
mSphere. 2023 Jun 22;8(3):e0066222. doi: 10.1128/msphere.00662-22. Epub 2023 Apr 18.
3
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
4
Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.第三剂 SARS-CoV-2 疫苗接种和突破性感染增强了针对关注变种的体液和细胞免疫。
Front Immunol. 2023 Mar 22;14:1120010. doi: 10.3389/fimmu.2023.1120010. eCollection 2023.
5
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.突破性感染后回忆性免疫的程度和时间由 SARS-CoV-2 变体决定。
Immunity. 2022 Jul 12;55(7):1316-1326.e4. doi: 10.1016/j.immuni.2022.05.018. Epub 2022 May 27.
6
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
7
Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity.勘误：感染SARS-CoV-2的奥密克戎和德尔塔变体所导致的突破性感染会使疫苗诱导的免疫力产生类似的重新激活。
Front Immunol. 2023 Jul 12;14:1249100. doi: 10.3389/fimmu.2023.1249100. eCollection 2023.
8
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine.病例报告：BNT162b2 疫苗接种后两次 COVID-19 突破感染的体液和细胞免疫演变。
Front Immunol. 2022 Feb 23;13:790212. doi: 10.3389/fimmu.2022.790212. eCollection 2022.
9
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.中国天津地区针对 SARS-CoV-2 奥密克戎 BA.1 变异株疫苗突破性感染后五种 SARS-CoV-2 变异株的中和抗体反应和 T 淋巴细胞变化的前瞻性研究。
Biomed Environ Sci. 2023 Jul 20;36(7):614-624. doi: 10.3967/bes2023.047.
10
Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 Treatment.SARS-CoV-2 疫苗接种时机对接受脉冲式抗 CD20 治疗的多发性硬化症患者很重要。
Neurol Neuroimmunol Neuroinflamm. 2022 Oct 12;9(6). doi: 10.1212/NXI.0000000000200031. Print 2022 Nov.
Zotero 插件